A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care
Launched by UNIVERSITY OF WASHINGTON · Aug 6, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help women who are experiencing postpartum depression, which is a type of depression that can occur after having a baby. The study aims to see if a special parenting program, combined with regular care, can improve mental health and parenting skills more effectively than regular care alone. Researchers want to find out how well this program works and if mothers find it helpful and easy to use.
To participate in this trial, women must be English-speaking, pregnant, and between 13 to 24 weeks along in their pregnancy. They should also be at least 18 years old and have a certain level of depression as measured by a screening tool. However, women with severe substance use issues, active thoughts of self-harm, certain serious mental health conditions, or multiple pregnancies are not eligible to join. If you decide to participate, you can expect to receive support through the parenting program and regular check-ups to track your mental health and parenting experiences. This study is currently recruiting participants, and it offers an opportunity to contribute to important research that may help other mothers in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • English speaking pregnant women between gestational age (GA) 13 - 24 weeks
- • ≥ 18 years,
- • EPDS score ≥10,
- • Ability to send and receive text messages (TM)
- Exclusion Criteria:
- • Severe substance use disorder in the past 6 months (score of 4 or above on the Alcohol Use Disorders Test AUDIT-C or a score of 6 or more on the Drug Abuse Screening Test (DAST).
- • Active suicidal ideation as measured by follow up to a positive answer to question 10 on the EPDS.
- • Bipolar disorder (Composite International Diagnostic Interview score ≥7) or psychotic disorder (assessed by chart review);
- • Multiple gestation (assessed by self-report and medical record);
- • Ongoing active treatment with psychotropic medications by mental health specialist (but not a PCP or Obstetrician).
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Amritha S Bhat, MD, MPH
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials